StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.87−0.00 (-0.52%)

Close on Nov 18, 2026Market cap $6.99MP/E –Yield –

Immuron shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2026 it was 297M, up 28.6% from the year before. The highest annual figure on record is 297M in fiscal 2026.

Annual shares outstanding

PeriodPeriod endValueChange
FY2026Jun 30, 2026297M+28.6%
FY2025Jun 30, 2025231M+1.4%
FY2024Jun 30, 2024228M+0.0%
FY2023Jun 30, 2023228M+0.1%
FY2022Jun 30, 2022228M–

More Immuron figures

See a number that looks wrong?